Prescribing Strategies for Genitourinary Syndrome of Menopause (GSM)

​Prescribing Strategies for Genitourinary Syndrome of Menopause (GSM)

​Genitourinary Syndrome of Menopause (GSM) affects up to 80% of women after menopause, yet it remains one of the most underdiagnosed and undertreated conditions in women's health. Many patients silently struggle with symptoms such as vaginal dryness, painful intercourse, recurrent urinary tract infections, urinary urgency, and irritation—often unaware that highly effective treatment options are available.

​Join Christine Hart Kress, DNP, WHNP-BC, for this practical, evidence-based webinar designed to help clinicians confidently diagnose, counsel, and prescribe treatments for GSM. Through real-world clinical scenarios, participants will gain a clear understanding of current treatment guidelines, including non-hormonal therapies, local vaginal estrogen, DHEA, ospemifene, and patient-centered prescribing considerations. The session will also address common misconceptions around hormone safety, counseling strategies for hesitant patients, and approaches for women with complex medical histories, including breast cancer survivors.

​Whether you are new to prescribing for GSM or looking to refine your clinical approach, this session will provide actionable insights you can immediately implement in practice to improve quality of life for your patients.